about
Achaete-scute homolog-1 linked to remodeling and preneoplasia of pulmonary epitheliumMicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitorsSomatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signatureTCF/beta-catenin plays an important role in HCCR-1 oncogene expressionGallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes.Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different originBlockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men.An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response.Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapyA unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.The future of antisense therapy: combination with anticancer treatments.Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studiesc-Myb is required for progenitor cell homeostasis in colonic crypts.Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Koreac-Myb a stem-progenitor cell regulator in multiple tissue compartments.Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis.Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffeningc-MYB regulates cell growth and DNA damage repair through modulating MiR-143.Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex.Myb controls intestinal stem cell genes and self-renewal.Leukemia suppressor function of Egr-1 is dependent on transforming oncogene.Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells.The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target.Oxidative Stress and Hepatic Stellate Cells: A PARADOXICAL RELATIONSHIP.Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma.Exploration of binding affinity and selectivity of brucine with G-quadruplex in the c-myb proto-oncogene by electrospray ionization mass spectrometry.Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells
P2860
Q24306139-A082734E-D866-458E-92F6-742BE83A2712Q24653639-5C7518BB-B492-4AB4-B0B4-CA1B807E1D37Q33363918-FEE757A2-3743-441C-8A11-16FB6C974A10Q33444348-BD51E2A7-E03E-464C-A87B-FF02C9702BB1Q33808898-015F7BA5-506B-42EE-91C2-3AF9F8A06784Q34121618-A5B18AB0-FDAA-446B-BADA-EBAC82F77C13Q34307027-F165EF18-0FED-4A59-9C66-FBC0E08D5D35Q34312055-B70536E6-FB10-4165-B0E3-675D6470B6ACQ34453171-9BDA2EF1-B679-4983-A37D-FD0C99D01F2DQ34503882-85EC505C-87C5-4A54-B594-83603C605953Q34689044-A302E123-32BC-4E7A-B64C-2301D3EDC919Q35149666-F943E273-1F86-4AD2-80BC-D9519BD24C03Q35537902-3F584544-4CB7-41F0-B24C-2DB5080C79E5Q35551139-C0CDB5EC-29EC-41E8-8AA9-B02102FC5A64Q35643802-C0BA9FAE-D87A-47B9-B709-227915C3D5D8Q35676661-69828F60-BAAD-4FD4-859D-516BD70315EBQ35963023-5B2E71B5-9D29-4AEB-A691-B98F4E63FB95Q36113270-E0993AA8-9C00-4405-94A2-14C83BABD137Q36336577-1E738936-3AED-4FFB-9C03-519DCD17C02AQ36902777-E334E374-6C8B-4DC8-AFCB-C7F5C6BA341FQ37730897-E92BDFAE-D768-4721-AF51-7D51D121D2E6Q38256411-0A73F665-8E30-48BE-9D2E-9AB2B9681A3FQ38295458-6AE94EAA-472E-4902-BE8E-3BF628EEF1CCQ38696174-1CDFEE12-DBBD-4856-8F60-90FA970F55F3Q38917058-9AE29DDF-2F82-4079-AB63-654F093CA4F8Q39002280-1268C656-18B1-41E7-8152-34BCD2FD1508Q39458366-3391DB27-AC52-4D89-90C6-E6950AF474C8Q39957933-0B3F8569-169B-4427-B61E-D37BDA539876Q40332263-D8000594-2D59-4502-81B6-309766E990C7Q41043732-6E03C085-B12D-4EE4-859B-C0A36BB951AAQ41334406-5305CB2D-F69D-48E1-9E8E-96021B6514A9Q46588700-6C9013F2-C0D4-4D9A-9930-F10154A8BB4FQ51566887-E35BEA0C-B43D-4278-B94F-0559088D2FDEQ52611165-C516142C-2500-433D-B59C-0396D647F83EQ53303481-A71B7FB1-BB67-484F-AD97-6AA349E0574FQ57039811-A2D56774-B024-488C-A5F2-D56544E521CE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Targeting c-Myb expression in human disease.
@ast
Targeting c-Myb expression in human disease.
@en
type
label
Targeting c-Myb expression in human disease.
@ast
Targeting c-Myb expression in human disease.
@en
prefLabel
Targeting c-Myb expression in human disease.
@ast
Targeting c-Myb expression in human disease.
@en
P2093
P2860
P356
P1476
Targeting c-Myb expression in human disease.
@en
P2093
Anna L Barton
Robert G Ramsay
Thomas J Gonda
P2860
P304
P356
10.1517/14728222.7.2.235
P407
P577
2003-04-01T00:00:00Z